Atlantic Petroleum P/F
Tórshavn, Faroe Islands, 2021-01-08 (GLOBE NEWSWIRE) -- P/F Atlantic Petroleum (NASDAQ OMX: ATLA DKK & Oslo Stock Exchange: ATLA NOK) hereby announces the financial calendar for 2021 with the following dates:
- Wednesday 31st March: Annual Accounts 2020 to be issued.
- Friday 30th April: Annual General Meeting.
- Monday 31st May: 1st Quarter 2021 Condensed Consolidated Interim Report to be issued.
- Tuesday 31st August: 2nd Quarter 2021 Condensed Consolidated Interim Report to be issued.
- Tuesday 30th November: 3rd Quarter 2021 Condensed Consolidated Interim Report to be issued.
Atlantic Petroleum in brief:
Atlantic Petroleum participates in oil and gas joint ventures with reputable, international partners. Atlantic Petroleum P/F is based in Tórshavn, Faroe Islands, and the Company has subsidiaries in UK and Ireland. Atlantic Petroleum’s existing shares are listed on NASDAQ OMX Copenhagen and on Oslo Stock Exchange.
Further Details:
Further details can be obtained from Mark T. Højgaard, CEO (markh@petroleum.fo ). This announcement will be available, together with other information about Atlantic Petroleum, on the Company's website: www.petroleum.fo .
Announcement no.2/2021
Issued 8-1-2021
P/F Atlantic Petroleum
Lucas Debesargøta 8
P.O. Box 1228
FO-110 Tórshavn
Faroe Islands
Website: www.petroleum.fo
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
VoltaGrid LLC20.10.2025 23:15:00 CEST | Press release
VoltaGrid and Halliburton Announce Strategic Collaboration to Deliver Distributed Power Solutions for the Global Data Center Industry
Teva Pharmaceutical Industries Ltd20.10.2025 22:30:00 CEST | Press release
Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe
Vicor Corporation20.10.2025 21:50:00 CEST | Press release
Vicor steps up its IP licensing practice
Biotalys NV20.10.2025 18:00:00 CEST | Press release
Regulated information
Syensqo SA20.10.2025 17:45:00 CEST | Press release
Syensqo - Acquisition of own shares
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom